What You Really Need to Know About Semaglutide, Tirzepatide, and Medical Weight Loss At Peak Medical, we understand that weight loss is deeply personal and more than just a number on the scale—it’s about reclaiming your energy, confidence, and overall well-being. As spring turns to summer, many people are [...]
When it comes to heart health, weight plays a significant role in overall cardiovascular risk. Excess weight, particularly around the abdomen, increases the likelihood of conditions such as high blood pressure, elevated cholesterol, and insulin resistance—all of which contribute to heart disease. Fortunately, advancements in medical weight loss offer solutions that not only [...]
At Peak Medical, we believe that maintaining health and vitality is crucial at every stage of life. Semaglutide and Tirzepatide—medications initially developed for managing type 2 diabetes—are gaining recognition for their broader health benefits, extending far beyond blood sugar control. These GLP-1 (glucagon-like peptide-1) receptor agonists offer powerful advantages for adults of all ages, [...]
As we age, maintaining health and vitality becomes increasingly important. One area gaining attention is the use of GLP-1 (glucagon-like peptide-1) receptor agonists. Initially developed for managing type 2 diabetes, these medications are now recognized for their broader benefits, particularly in promoting healthy aging and longevity. Despite their potential, these medications remain underutilized [...]
Semaglutide and Tirzepatide have gained significant attention in the medical community primarily for their effectiveness in managing type 2 diabetes and facilitating weight loss. However, these medications, classified as GLP-1 receptor agonists (for Semaglutide) and dual GLP-1/GIP receptor agonists (for Tirzepatide), are now being explored for a variety of other potential health benefits beyond [...]
Semaglutide Program from Peak Medical It's being touted as a game-changer in the world of weight loss drugs because, well, it actually works. A large study was published recently in the New England Journal of Medicine showing some pretty impressive weight loss effects in non-diabetics taking semaglutide. 50% of people [...]
